LENZ Total Debt To Capitalization from 2010 to 2024

LENZ Stock   37.30  1.05  2.90%   
LENZ Therapeutics Total Debt To Capitalization yearly trend continues to be fairly stable with very little volatility. Total Debt To Capitalization is likely to outpace its year average in 2024. During the period from 2010 to 2024, LENZ Therapeutics Total Debt To Capitalization regression line of annual values had r-squared of  0.67 and arithmetic mean of (113.08). View All Fundamentals
 
Total Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.001395
Current Value
0.001465
Quarterly Volatility
82.76456602
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LENZ Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LENZ Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 48 K or Other Operating Expenses of 55.6 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0 or PTB Ratio of 0.58. LENZ financial statements analysis is a perfect complement when working with LENZ Therapeutics Valuation or Volatility modules.
  
Check out the analysis of LENZ Therapeutics Correlation against competitors.
For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.

Latest LENZ Therapeutics' Total Debt To Capitalization Growth Pattern

Below is the plot of the Total Debt To Capitalization of LENZ Therapeutics over the last few years. It is LENZ Therapeutics' Total Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LENZ Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Total Debt To Capitalization10 Years Trend
Slightly volatile
   Total Debt To Capitalization   
       Timeline  

LENZ Total Debt To Capitalization Regression Statistics

Arithmetic Mean(113.08)
Geometric Mean3.51
Coefficient Of Variation(73.19)
Mean Deviation75.39
Median(169.62)
Standard Deviation82.76
Sample Variance6,850
Range170
R-Value0.82
Mean Square Error2,437
R-Squared0.67
Significance0.0002
Slope15.14
Total Sum of Squares95,900

LENZ Total Debt To Capitalization History

2024 0.001465
2023 0.001395
2020 0.00155

About LENZ Therapeutics Financial Statements

LENZ Therapeutics investors use historical fundamental indicators, such as LENZ Therapeutics' Total Debt To Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LENZ Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LENZ Stock Analysis

When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.